Skip to main content
Jaime Kaplan

Featured Patient Story

 Jaime Kaplan

My older sister, Barbara Kaplan, started having shortness of breath in October of 2019. She went to her internist in Miami, Florida, and a chest x-ray which showed fluid in her lungs. Her internist immediately referred her to a cardiologist who suspected amyloidosis. She was diagnosed a few days later and was started on Vyndamax shortly after. Her 3 siblings were advised to get tested for the gene. Our two brothers were quickly tested and both were deemed negative. Our mother was tested and is negative as well. Our dad is deceased.

read more

Latest News Story Headlines

2024 Fall Newsletter
Be sure to catch up on the latest happenings in our fall newsletter.
read full article
Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug.

read full article
Alnylam Reports Positive Topline Results from HELIOS-B Phase 3 Study of Vutrisiran, Achieving Statistical Significance on Primary and All Secondary Endpoints in Both Overall and Monotherapy Populations

Jun 24, 2024

read full article

Calendar & Upcoming Events

Webinar: Breaking negative thought loops

Webinar Session, Wednesday, October 9, 2024 at 6 PM (ET)

view all event details

Webinar: Accessing your medical records with MyChart

Webinar Session, Wednesday, October 16, 2024 at 6 PM (ET)

view all event details

Webinar: Updates in AL amyloidosis: Fast Forward in 2024!

Webinar:  Updates in AL amyloidosis: Fast Forward in 2024!

Speaker:  Dr. Heather Landau, MD  Memorial Sloan Kettering Cancer Center

view all event details

Amyloidosis Videos

Our Latest Webinar

UPDATES IN ATTR CARDIAC AMYLOIDOSIS: What's new and exciting for 2024

Frederick L. Ruberg, MD, Omar K. Siddiqi, MD – Boston Medical Center/Boston University – Boston, MA

Sign Up for the Latest Updates

Get news from Amyloidosis Foundation
in your inbox

By submitting this form, you are consenting to receive marketing emails from : Amyloidosis Foundation, 7151 N. Main St., Suite 2, Clarkston, MI, 48346, US, https://www.amyloidosis.org. You can revoke your consent to receive emails at any time by using SafeUnsubscribe© link, found at the bottom of every email. Emails are serviced by Constant Contract.